Edap TMS SA (EDAP)
2.47
-0.02
(-0.80%)
USD |
NASDAQ |
Nov 22, 16:00
2.47
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Cash from Operations (Quarterly): -5.573M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -5.573M |
June 30, 2024 | -6.625M |
March 31, 2024 | -4.073M |
December 31, 2023 | -4.726M |
September 30, 2023 | -1.686M |
June 30, 2023 | -5.121M |
March 31, 2023 | -4.357M |
December 31, 2022 | -6.839M |
Date | Value |
---|---|
September 30, 2022 | 2.318M |
June 30, 2022 | 0.1117M |
March 31, 2022 | 1.220M |
December 31, 2021 | 3.168M |
September 30, 2021 | 1.199M |
June 30, 2021 | -0.8892M |
March 31, 2021 | 1.782M |
March 31, 2020 | 2.182M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.839M
Minimum
Dec 2022
3.168M
Maximum
Dec 2021
-1.744M
Average
-1.288M
Median
Cash from Operations (Quarterly) Benchmarks
DBV Technologies SA | -22.46M |
Cellectis SA | -5.829M |
Genfit SA | -- |
Adaptimmune Therapeutics PLC | -54.45M |
Akari Therapeutics PLC | -1.49M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -1.120M |
Cash from Financing (Quarterly) | 0.6422M |
Free Cash Flow | -24.95M |
Free Cash Flow Per Share (Quarterly) | -0.1797 |
Free Cash Flow to Equity (Quarterly) | -7.677M |
Free Cash Flow to Firm (Quarterly) | -6.693M |
Free Cash Flow Yield | -27.21% |